Company
Live Verdure Ltd
Headquarters: Melbourne, VIC, Australia
Market Cap
A$44.2 Million
AUD as of Jan. 1, 2024
US$30.1 Million
Live Verdure Ltd Categories
Australia Healthcare Drug Manufacturers—Specialty & GenericAustralia Healthcare Australia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Live Verdure Limited, together with its subsidiaries, produces and sells plant-based products under the 13 Seeds brand name in Australia. It offers hemp food, beauty, and nutraceutical products through its website and online channels. The company was formerly known as 13 Seeds Ltd. and changed its name to Live Verdure Limited in October 2020. Live Verdure Limited was founded in 2016 and is based in Melbourne, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Live Verdure Ltd has the following listings and related stock indices.
Stock: ASX: LV1 wb_incandescent